Positive Inotropic Effects of Imidazoline Derivatives Are Not Mediated via Imidazoline Binding Sites but α_1-Adrenergic Receptors

スポンサーリンク

概要

• 論文の詳細を見る

• Imidazoline−binding sites are non−adrenergic receptors and classified into I1/I2 subtypes.There is strong evidence that I1−binding sites, located in the rostro−ventrolateral medulla, are involved in regulation of blood pressure.However, less is known about the peripheral participation of I1−binding sites in cardiovascular reactions.Therefore, the aim of this study was to investigate whether specific imidazoline derivatives influence myocardial contractility and whether imidazoline binding sites are expressed in rat heart.Agmatine, clonidine and idazoxan failed to alter inotropy in left atria within the whole concentration range tested(1 nM−100μM), whereas cirazoline(1−100μM)and moxonidine(100μM)increase inotropy by about 20−30%.After pre−incubation with the α1−adrenoceptor antagonist prazosin, the cirazoline and moxonidine stimulated inotropy was antagonized, indicating more an α1−adrenergic and less an imidazoline binding site mediated mechanism.Radioligand−binding studies in membranes of left ventricles using [3H]−clonidine to specify I1−binding yielded KD values of 12.7μM, confirming the functional results of an absence of I1−binding sites in ventricles of rats.However, the existence of low affinity I2−binding sites determined by [3H]−idazoxan labeling could not be excluded since a KD of 0.5μM was calculated and since competition studies with guanabenz(Ki=0.1μM), clonidine(Ki=58.1μM)and moxonidine(Ki=129μM)confirmed the specificity of the I2−binding.

• 社団法人 日本薬理学会の論文
• 2000-09-01

著者

• Chun K.r.julian

  ドイツ

• Chun K.

  Iinstitute Of Experimental And Clinical Pharmacology And Toxicology Medical University Of Lubeck

• Raasch W

  Institute Of Experimental And Clinical Pharmacology And Toxicology Medical University Of Lubeck

• Dendorfer Andreas

  Institute Of Experimental And Clinical Pharmacology And Toxicology Medical University Of Lubeck

• RAASCH Walter

  Iinstitute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lubeck

• DENDORFER Andreas

  Iinstitute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lubeck

• DOMINIAK Peter

  Iinstitute of Experimental and Clinical Pharmacology and Toxicology, Medical University of Lubeck

• Dominiak P

  Institute Of Experimental And Clinical Pharmacology And Toxicology Medical University Of Lubeck

関連論文

• Positive Inotropic Effects of Imidazoline Derivatives Are Not Mediated via Imidazoline Binding Sites but α_1-Adrenergic Receptors
• Interactions of Ligands at Angiotensin II-Receptors and Imidazoline Receptors
• The Lipophilic Properties of Angiotensin I-Converting Enzyme Inhibitors Do Not Influence Their Diffusion Through Cultured Endothelium
• Pharmacology and Cardiovascular Implications of the Kinin-Kallikrein System
• Identification of Kallidin Degrading Enzymes in the Isolated Perfused Rat Heart

スポンサーリンク